Your browser doesn't support javascript.
loading
Attenuated FOLFIRINOX in the salvage treatment of gemcitabine-refractory advanced pancreatic cancer: a phase II study.
Kim, Jung Hoon; Lee, Sang-Cheol; Oh, Sung Yong; Song, Seo-Young; Lee, Namsu; Nam, Eun Mi; Lee, Soonil; Hwang, In Gyu; Lee, Hyo Rak; Lee, Kyu Taek; Bae, Sang-Byung; Kim, Han Jo; Jang, Joung Soon; Lim, Do Hyoung; Lee, Hyun Woo; Kang, Seok Yun; Kang, Jung Hun.
Afiliação
  • Kim JH; Department of Internal Medicine, Institute of Health Sciences, Gyeongsang National University, 15 Jinju-daero 816beon-gil, Jinju, 52727, Republic of Korea.
  • Lee SC; Divsion of Hematology and Oncology, Department of Internal Medicine, Soonchunhyang University Hospital Cheonan, Cheonan, 31151, Republic of Korea.
  • Oh SY; Department of Internal Medicine, Dong-A University Hospital, Busan, 49201, Republic of Korea.
  • Song SY; Department of Internal Medicine, Kangwon National University School of Medicine, Chuncheon, 24289, Republic of Korea.
  • Lee N; Divsion of Hematology and Oncology, Department of Internal Medicine, Soonchunhyang University Hospital Seoul, Seoul, 04401, Republic of Korea.
  • Nam EM; Department of Internal Medicine, Ewha Womans University, College of Medicine, Seoul, 07985, Republic of Korea.
  • Lee S; Department of Internal Medicine, Dankook University Hospital, Cheonan, 31116, Republic of Korea.
  • Hwang IG; Department of Internal Medicine, Chung-Ang University, College of Medicine, Seoul, 06973, Republic of Korea.
  • Lee HR; Division of Hematology and Medical Oncology, Department of Internal Medicine, Korea Cancer Hospital, Seoul, 01812, Republic of Korea.
  • Lee KT; Divsion of Hematology and Oncology, Department of Internal Medicine, Soonchunhyang University Hospital Cheonan, Cheonan, 31151, Republic of Korea.
  • Bae SB; Divsion of Hematology and Oncology, Department of Internal Medicine, Soonchunhyang University Hospital Cheonan, Cheonan, 31151, Republic of Korea.
  • Kim HJ; Divsion of Hematology and Oncology, Department of Internal Medicine, Soonchunhyang University Hospital Cheonan, Cheonan, 31151, Republic of Korea.
  • Jang JS; Department of Internal Medicine, Chung-Ang University, College of Medicine, Seoul, 06973, Republic of Korea.
  • Lim DH; Department of Internal Medicine, Dankook University Hospital, Cheonan, 31116, Republic of Korea.
  • Lee HW; Department of Hematology-Oncology, Ajou University Hospital, Suwon, 16499, Republic of Korea.
  • Kang SY; Department of Hematology-Oncology, Ajou University Hospital, Suwon, 16499, Republic of Korea.
  • Kang JH; Department of Internal Medicine, Institute of Health Sciences, Gyeongsang National University, 15 Jinju-daero 816beon-gil, Jinju, 52727, Republic of Korea. newatp@naver.com.
Cancer Commun (Lond) ; 38(1): 32, 2018 06 04.
Article em En | MEDLINE | ID: mdl-29866170

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Terapia de Salvação Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Terapia de Salvação Idioma: En Ano de publicação: 2018 Tipo de documento: Article